The Role of TG2 in Regulating S100A4-Mediated Mammary Tumour Cell Migration

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wang, Zhuo ^a   Griffin, Martin ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; ENZYME INHIBITOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2 INHIBITOR; PROTEIN KINASE C ALPHA; R 294; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA; SYNDECAN 4; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BREAST CELL; BREAST TUMOR; CANCER CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; FAR WESTERN BLOTTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CELL MOVEMENT; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; INTEGRIN ALPHA5BETA1; ISOENZYMES; MAMMARY NEOPLASMS, ANIMAL; PEPTIDES; PROTEIN KINASE C-ALPHA; RATS; RNA, SMALL INTERFERING; S100 PROTEINS; SIGNAL TRANSDUCTION; SYNDECAN-4; TRANSGLUTAMINASES;

EID: 84874574529     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057017     Document Type: Article

References (39)

1. Ismail TM, Zhang S, Fernig DG, Gross S, Martin-Fernandez ML, et al. (2010) Self-association of calcium-binding protein S100A4 and metastasis. J Biol Chem 285: 914-922.
2. Ismail NI, Kaur G, Hashim H, Hassan MS, (2008) S100A4 overexpression proves to be independent marker for breast cancer progression. Cancer Cell Int 8: 12.
3. Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS, et al. (2005) Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 24: 1445-1454.
4. Donato R, (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540-551.
5. Donato R, (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7: 711-724.
6. Kim TH, Kim HI, Soung YH, Shaw LA, Chung J, (2009) Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion. Mol Cancer Res 7: 1605-1612.
7. Kiryushko D, Novitskaya V, Soroka V, Klingelhofer J, Lukanidin E, et al. (2006) Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol Cell Biol 26: 3625-3638.
8. Kotsakis P, Griffin M, (2007) Tissue transglutaminase in tumour progression: friend or foe? Amino Acids 33: 373-384.
9. Collighan RJ, Griffin M, (2009) Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36: 659-670.
10. Akimov SS, Krylov D, Fleischman LF, Belkin AM, (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. Journal of Cell Biology 148: 825-838.
11. Scarpellini A, Germack R, Lortat-Jacob H, Muramtsu T, Johnson TS, et al. (2009) Heparan sulphate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. J Biol Chem.
12. Wang Z, Collighan RJ, Pytel K, Rathbone DL, Li X, et al. (2012) Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling. J Biol Chem 287: 13063-13083.
13. Wang Z, Griffin M, (2012) TG2, a novel extracellular protein with multiple functions. Amino Acids 42: 939-949.
14. Antonyak MA, Li B, Regan AD, Feng Q, Dusaban SS, et al. (2009) Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J Biol Chem 284: 17914-17925.
15. Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K, (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26: 2459-2470.
16. Wang Z, Collighan RJ, Gross SR, Danen EH, Orend G, et al. (2010) RGD independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 and {alpha}5{beta}1 integrin co-signaling. J Biol Chem 285: 40212-40229.
17. Ruse M, Lambert A, Robinson N, Ryan D, Shon KJ, et al. (2001) S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 40: 3167-3173.
18. Leblanc A, Day N, Menard A, Keillor JW, (1999) Guinea pig liver transglutaminase: A modified purification procedure affording enzyme with superior activity in greater yield. Protein Expression and Purification 17: 89-95.
19. Griffin M, Mongeot A, Collighan R, Saint RE, Jones RA, et al. (2008) Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorganic & Medicinal Chemistry Letters 18: 5559-5562.
20. Chen D, Davies MP, Rudland PS, Barraclough R, (1997) Transcriptional down regulation of the metastasis-inducing S100A4 (p9Ka) in benign but not in malignant rat mammary epithelial cells by GC-factor. J Biol Chem 272: 20283-20290.
21. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, et al. (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699-22708.
22. Perez Alea M, Kitamura M, Martin G, Thomas V, Hitomi K, et al. (2009) Development of an isoenzyme-specific colorimetric assay for tissue transglutaminase 2 cross-linking activity. Anal Biochem 389: 150-156.
23. Wang Z, Telci D, Griffin M, (2011) Importance of syndecan-4 and syndecan-2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res 317: 367-381.
24. Jones RA, Wang Z, Dookie S, Griffin M (2012) The role of TG2 in ECV304 related vasculogenic mimicry. Amino Acids.
25. Kotsakis P, Wang Z, Collighan RJ, Griffin M, (2011) The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26. Amino Acids 41: 909-921.
26. Baumgartner W, Golenhofen N, Weth A, Hiiragi T, Saint R, et al. (2004) Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium. Histochemistry and Cell Biology 122: 17-25.
27. McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, et al. (2010) Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med 2: 349-370.
28. Verhaar R, Jongenelen CA, Gerard M, Baekelandt V, Van Dam AM, et al. (2011) Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of alpha-synuclein in a cellular model of Parkinson's disease. Neurochem Int. Epub ahead of print.
29. Schaertl S, Prime M, Wityak J, Dominguez C, Munoz-Sanjuan I, et al. (2010) A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors. Journal of Biomolecular Screening 15: 478-487.
30. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, et al. (2006) S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A 103: 14825-14830.
31. Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, et al. (2011) Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med 184: 699-707.
32. Pinkas DM, Strop P, Brunger AT, Khosla C, (2007) Transglutaminase 2 undergoes a large conformational change upon activation. Plos Biology 5: 2788-2796.
33. Garrett SC, Varney KM, Weber DJ, Bresnick AR, (2006) S100A4, a mediator of metastasis. J Biol Chem 281: 677-680.
34. Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, et al. (2008) Fibronectin tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin.
35. Parsons M, Keppler MD, Kline A, Messent A, Humphries MJ, et al. (2002) Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis. Mol Cell Biol 22: 5897-5911.
36. Verma A, Mehta K, (2007) Tissue transglutaminase-mediated chemoresistance in cancer cells. Drug Resistance Updates 10: 144-151.
37. Herman JF, Mangala LS, Mehta K, (2006) Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25: 3049-3058.
38. Griffin M, Casadio R, Bergamini CM, (2002) Transglutaminases: Nature's biological glues. Biochem J 368: 377-396.
39. Fischer J, Koblyakova Y, Latendorf T, Wu Z, Meyer-Hoffert U (2013) Cross Linking of SPINK6 by Transglutaminases Protects from Epidermal Proteases. J Invest Dermatol. Epub ahead of print.